Effects of bosentan on peripheral endothelial function in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension

Abstract. Endothelin receptor antagonists (ERAs) have been shown to improve the prognosis of patients with pulmonary arterial hypertension (PAH). However, the effect of the oral dual ERA bosentan on peripheral endothelial dysfunction (PED), as assessed by flow-mediated vasodilation (FMD), in patient...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pulm Circ
Autori principali: Hirashiki, Akihiro, Adachi, Shiro, Nakano, Yoshihisa, Kamimura, Yoshihiro, Shimokata, Shigetake, Takeshita, Kyosuke, Murohara, Toyoaki, Kondo, Takahisa
Natura: Artigo
Lingua:Inglês
Pubblicazione: University of Chicago Press 2016
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4869920/
https://ncbi.nlm.nih.gov/pubmed/27252842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/685715
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi